Open in interactive viewer → charts, metric popovers & call review

Intrum: The Balance Sheet Is Fixed. The P&L Is Still Broken.

The Q3 capital raise and asset sale cut servicing leverage to 4.5, but Germany and the UK keep the servicing recovery on hold.
INTRUM.ST · Earnings Call · 2026-10-23

A cleaner balance sheet, a dirtier P&L

Intrum did the hard balance-sheet work in Q3. The capital raise and asset sale closed, and servicing leverage fell to 4.5 from 5.7 at the start of the year, putting the company on a path toward 3.0 in 2028. That is the headline management wants investors to focus on. “It feels like it's a Q2 event, but we actually did close the capital raise and the asset sale in Q3. And that, together, coupled with cost control, moves the service leverage to 4.5.” — Johan Akerblom, President and Chief Executive Officer (CEO) · 2026-10-23 The problem is that the income statement did not cooperate. The asset sale and capital raise repaired the debt stack, but the servicing top line is still shrinking. “The negative trend on the income side, unfortunately continues from H1. And the drivers of that is mainly that we have development not according to plan in Germany and U.K.” — Johan Akerblom, President and Chief Executive Officer (CEO) · 2026-10-23 That is the central tension of this report: the balance sheet is cleaner, but the P&L is not.

Germany is the write-off; the UK is the wait

Germany is no longer a soft patch. Intrum took a SEK 1.5 billion goodwill impairment in Q3 and wrote off the remaining German goodwill entirely. Management described the problem as operational and infrastructural, not merely cyclical.

Germany, there we have operational issues, and we're basically rebuilding the platform. We're changing the infrastructure... there needs to be a complete rebuild, and that's what we're doing.

Johan Akerblom, President and Chief Executive Officer (CEO) · 2026-10-23
That is a complete rebuild, not a tweak. The UK is framed differently: a legacy acquisition, a client loss, an integration that took longer than expected, and a new managing director who joined on 1 September from Coeo. Management hired a new commercial lead and lifted sales capacity by more than 30% across the board. But new sales capacity takes six to twelve months to show up in the top line, and the company is not pretending otherwise. “we want to be a bit humble in terms of giving any forecast for 2027” — Masih Yazdi, Chief Financial Officer (CFO) · 2026-10-23. That humility is itself the story. On the prior call, management was still arguing it could turn the UK and Germany around. “U.K. and Germany are 2 markets where we have been underperforming, and we need to turn that trend around.” — Johan Akerblom, CEO · 2026-08-28 Three months later, Germany has been written down and the UK has been handed to a new commercial team. The Germany problem is now explicitly structural; the UK is still presented as fixable. Investors should treat that distinction as the key swing factor for 2027.

The capital allocation triangle: bonds, portfolios, costs

With the balance sheet repaired, Intrum faces a three-way choice: buy back bonds, invest in portfolios, or spend on restructuring. Management says the acceleration of investments is real: SEK 617 million was underwritten in Q3 at a blended 17% IRR, and the company still aims for replenishing levels of around SEK 3 billion annually. Collections came in at 101% of forecast and 107% versus the original forecast. But the funding market has turned. “it is not a market where we will refinance in because the financial cost of that will be too large” — Masih Yazdi, Chief Financial Officer (CFO) · 2026-10-23. The EUR 190 million 2027 bond is covered by liquidity; the next real refinancing is 2028, when the RCF is expected to be materially smaller and replaced with bond issuance. The second lien incurrence test matters: the 2031 1.5-lien bond can only be used to refinance second liens if total leverage is below 3.5x. That is why bond buybacks and portfolio purchases are competing for the same cash. The cost lever is the most credible part of the plan. Intrum is targeting a total cost base of SEK 11 billion in 2027, down from SEK 11.8 billion on a rolling 12-month basis in Q3. The operational excellence program has been widened from 7 countries to 17, and management expects roughly 1,000 fewer FTEs by 2028. “roughly having around 1,000 fewer FTEs than we have today” — Masih Yazdi, Chief Financial Officer (CFO) · 2026-10-23. The servicing margin held at 25% year on year despite the revenue decline, and the 2030 target remains 30% to 35%. But cost cuts alone do not fix a revenue problem; they mainly buy time. The prior call already flagged that weaker income would push the company toward the lower end of its cost target. “if income is higher, we'll probably be closer to the SEK 11 billion and income is lower, it's going to be closer to the SEK 10 billion.” — Masih Yazdi, CFO · 2026-08-28 That logic has not changed; it has simply become more urgent.

What the keywords and the market tape say

Intrum's own keyword trail shows the shift. The Q3 board is dominated by negative effect, balancing act, Spanish business, net financial expense, and refinancing — balance-sheet and portfolio-repair language rather than growth language. The traditional markets theme remains, but it is now a defensive story: traditional markets excluding Germany grew 3%, while Greece, Italy and Spain declined roughly as expected. Spain is the quiet subplot. Management would not comment on sale rumours, but confirmed the Spanish servicing market has a lower margin than the group average. A Spanish disposal would be another asset sale dressed as portfolio optimisation. The global keyword board for the quarter is full of bank-capital and rates noise — IRB model, Fed rate hike, mortgage universe — none of which explains Intrum. This is not a company riding a sector wave. It is a company repairing its own capital structure while its two biggest problem markets lag. The absence of a price tape in the context means we cannot lean on a return outlier; the evidence has to come from the transcript, and the transcript is clear enough: leverage is better, costs are coming down, but the revenue trough has not been proven. The bull case is that the UK and Germany are approaching their trough, cost cuts accelerate into 2027, and the investment book starts to grow again at acceptable returns. The bear case is that Germany needed a full rebuild, the UK needs a commercial rebuild, and the 2028 leverage target depends on EBITDA that may not arrive on schedule. Intrum has bought itself time with the capital raise and asset sale. Q4 and the 2027 guidance will tell us whether time is enough.